Your browser doesn't support javascript.
loading
Cerebrospinal fluid neurofilament light predicts the rate of executive function decline in younger-onset dementia.
Walia, N; Eratne, D; Loi, S M; Li, Q-X; Varghese, S; Malpas, C B; Walterfang, M; Evans, A H; Parker, S; Collins, S J; Masters, C L; Velakoulis, D.
Afiliação
  • Walia N; Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia; Neuropsychiatry, The Royal Melbourne Hospital, Parkville, VIC, Australia. Electronic address: nirbaan.walia@austin.org.au.
  • Eratne D; Neuropsychiatry, The Royal Melbourne Hospital, Parkville, VIC, Australia; Melbourne Neuropsychiatry Centre & Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia; Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
  • Loi SM; Neuropsychiatry, The Royal Melbourne Hospital, Parkville, VIC, Australia; Melbourne Neuropsychiatry Centre & Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia.
  • Li QX; National Dementia and Diagnostics Laboratory, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.
  • Varghese S; National Dementia and Diagnostics Laboratory, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.
  • Malpas CB; Clinical Outcomes Research Unit (CORe), Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia; Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Walterfang M; Neuropsychiatry, The Royal Melbourne Hospital, Parkville, VIC, Australia; Melbourne Neuropsychiatry Centre & Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia; Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
  • Evans AH; Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Parker S; Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia; Neuropsychiatry, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Collins SJ; National Dementia and Diagnostics Laboratory, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia; Department of Medicine (RMH), The University of Melbourne, Parkville, VIC, Australia.
  • Masters CL; National Dementia and Diagnostics Laboratory, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.
  • Velakoulis D; Neuropsychiatry, The Royal Melbourne Hospital, Parkville, VIC, Australia; Melbourne Neuropsychiatry Centre & Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia; Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
J Neurol Sci ; 432: 120088, 2022 Jan 15.
Article em En | MEDLINE | ID: mdl-34922179
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article